RecruitingNCT06711562
Model-informed Individualized Treatment of Anti-infective Drugs
Model-informed Individualized Treatment of Anti-infective Drugs in Patients With Osteoarticular Infections
Sponsor
Shandong University
Enrollment
300 participants
Start Date
Oct 12, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
The study aims to optimize individualized treatment of anti-infective drugs in osteoarticular infections by analyzing drug exposure in patients blood and/or tissues using population pharmacokinetics.
Eligibility
Inclusion Criteria1
- Patients with suspected/confirmed osteoarticular infections who are undergoing anti-infective drug therapy.
Exclusion Criteria2
- Pregnant/lactating women.
- There are other factors that the researchers think are not suitable for inclusion.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGAnti-Infective Drugs
Anti-infective drugs are administered using the traditional clinical dosing regimen, with no interventions.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06711562